Kara Rice

Title: Innovations by Kara Rice in Hemophilia A Treatment

Introduction

Kara Rice is an accomplished inventor based in Waltham, MA (US). She has made significant contributions to the field of medicine, particularly in the treatment of hemophilia A. Her innovative approach has the potential to improve the lives of many individuals affected by this condition.

Latest Patents

Kara Rice holds a patent for her groundbreaking work titled "Methods of treating hemophilia A." This patent outlines a method for treating hemophilia A in human subjects by administering a chimeric polypeptide. The polypeptide comprises a factor VIII (FVIII) protein and a von Willebrand factor (VWF) fragment that includes a D' domain and a D3 domain of VWF at a specific dosing interval. This innovative treatment method represents a significant advancement in hemophilia care.

Career Highlights

Kara Rice is currently associated with Bioverativ Therapeutics Inc., where she continues to develop and refine her innovative treatments. Her work is characterized by a commitment to improving patient outcomes and advancing medical science.

Collaborations

Kara has collaborated with notable colleagues, including Ekta Seth Chhabra and Alison Innes. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the field of hemophilia treatment.

Conclusion

Kara Rice's contributions to the treatment of hemophilia A exemplify the impact of innovation in medicine. Her patent and ongoing work at Bioverativ Therapeutics Inc. highlight her dedication to improving the lives of those affected by this condition.